Shopping Cart 0
Cart Subtotal
USD 0

BioStar Pharmaceuticals Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Download Option: Yes
Deliverable Format : Excel, PDF viewable on the website via username

Corporate User License
USD 750

Details

Summary

BioStar Pharmaceuticals Inc (BioStar) is a developer, manufacturer and marketer of pharmaceutical and healthcare supplement products for various diseases and conditions. The company offers products such as huangyangning tablets, hyperthyroidism capsules, danshen granule, aoxing oleanolic acid capsule, and taohuasan and tianqi dysmenorrhea capsules. Its aoxing oleanolic acid capsule is an over-the-counter medicine used for the treatment of chronic hepatitis B. BioStar's hyperthyroidism capsules are used for the patients of hyperthyroidism with the symptoms of palpitations, sweating, irritability, dry throat, rapid pulse, and others. The company sells its products across China. BioStar is headquartered in Xianyang, China.

BioStar Pharmaceuticals Inc-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

BioStar Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

BioStar Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

BioStar Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

BioStar Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

BioStar Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

BioStar Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deal Details 10

Partnerships 10

Biostar Pharma Enters into R&D Agreement with Northwest University 10

Biostar Pharma Enters Into Co-Development Agreement With Shaanxi University of Chinese Medicine For Liver Cancer Drug 11

Biostar Pharma Enters Into Co-Development Agreement With Fourth Military Medical University 12

Equity Offering 13

Biostar Pharma Raises USD2 Million in Private Placement of Shares 13

Biostar Pharma Announces Private Placement Of Shares And Warrants For USD 4 Million 14

Acquisition 15

Biostar Pharma to Acquire Xianyang Yongsheng Health Products 15

BioStar Pharmaceuticals Inc-Key Competitors 16

BioStar Pharmaceuticals Inc-Key Employees 17

BioStar Pharmaceuticals Inc-Locations And Subsidiaries 18

Head Office 18

Other Locations & Subsidiaries 18

Recent Developments 19

Financial Announcements 19

Nov 20, 2017: Biostar Pharmaceuticals Announces Its Quarterly Results for Nine Months Ended September 30, 2017 19

Nov 15, 2017: Biostar Pharmaceuticals Announces Its Quarterly Results for Three Months Ended June 30, 2017 20

May 19, 2017: Biostar Pharmaceuticals Announces Its Quarterly Results for Three Months Ended March 31, 2017 21

Apr 13, 2017: Biostar Pharmaceuticals Announces Its Annual Results for The Year Ended December 31, 2016 22

Legal and Regulatory 23

Feb 07, 2018: Shaanxi Aoxing Pharmaceutical Renewed its GMP Certification 23

Other Significant Developments 24

Feb 21, 2018: Biostar Pharmaceuticals Announces Plans to Launch a New eCommerce Sales Platform 24

Appendix 25

Methodology 25

About GlobalData 25

Contact Us 25

Disclaimer 25


List Of Figure

List of Figures

BioStar Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

BioStar Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

BioStar Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

BioStar Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

BioStar Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

BioStar Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

BioStar Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

BioStar Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8


List Of Table

List of Tables

BioStar Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Key Facts 2

BioStar Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

BioStar Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

BioStar Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

BioStar Pharmaceuticals Inc, Deals By Therapy Area, 2012 to YTD 2018 8

BioStar Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

Biostar Pharma Enters into R&D Agreement with Northwest University 10

Biostar Pharma Enters Into Co-Development Agreement With Shaanxi University of Chinese Medicine For Liver Cancer Drug 11

Biostar Pharma Enters Into Co-Development Agreement With Fourth Military Medical University 12

Biostar Pharma Raises USD2 Million in Private Placement of Shares 13

Biostar Pharma Announces Private Placement Of Shares And Warrants For USD 4 Million 14

Biostar Pharma to Acquire Xianyang Yongsheng Health Products 15

BioStar Pharmaceuticals Inc, Key Competitors 16

BioStar Pharmaceuticals Inc, Key Employees 17

BioStar Pharmaceuticals Inc, Subsidiaries 18

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Company Profile

Company Profile Title

Summary

BioStar Pharmaceuticals Inc (BioStar) is a developer, manufacturer and marketer of pharmaceutical and healthcare supplement products for various diseases and conditions. The company offers products such as huangyangning tablets, hyperthyroidism capsules, danshen granule, aoxing oleanolic acid capsule, and taohuasan and tianqi dysmenorrhea capsules. Its aoxing oleanolic acid capsule is an over-the-counter medicine used for the treatment of chronic hepatitis B. BioStar's hyperthyroidism capsules are used for the patients of hyperthyroidism with the symptoms of palpitations, sweating, irritability, dry throat, rapid pulse, and others. The company sells its products across China. BioStar is headquartered in Xianyang, China.

BioStar Pharmaceuticals Inc-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

BioStar Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

BioStar Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

BioStar Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

BioStar Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

BioStar Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

BioStar Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deal Details 10

Partnerships 10

Biostar Pharma Enters into R&D Agreement with Northwest University 10

Biostar Pharma Enters Into Co-Development Agreement With Shaanxi University of Chinese Medicine For Liver Cancer Drug 11

Biostar Pharma Enters Into Co-Development Agreement With Fourth Military Medical University 12

Equity Offering 13

Biostar Pharma Raises USD2 Million in Private Placement of Shares 13

Biostar Pharma Announces Private Placement Of Shares And Warrants For USD 4 Million 14

Acquisition 15

Biostar Pharma to Acquire Xianyang Yongsheng Health Products 15

BioStar Pharmaceuticals Inc-Key Competitors 16

BioStar Pharmaceuticals Inc-Key Employees 17

BioStar Pharmaceuticals Inc-Locations And Subsidiaries 18

Head Office 18

Other Locations & Subsidiaries 18

Recent Developments 19

Financial Announcements 19

Nov 20, 2017: Biostar Pharmaceuticals Announces Its Quarterly Results for Nine Months Ended September 30, 2017 19

Nov 15, 2017: Biostar Pharmaceuticals Announces Its Quarterly Results for Three Months Ended June 30, 2017 20

May 19, 2017: Biostar Pharmaceuticals Announces Its Quarterly Results for Three Months Ended March 31, 2017 21

Apr 13, 2017: Biostar Pharmaceuticals Announces Its Annual Results for The Year Ended December 31, 2016 22

Legal and Regulatory 23

Feb 07, 2018: Shaanxi Aoxing Pharmaceutical Renewed its GMP Certification 23

Other Significant Developments 24

Feb 21, 2018: Biostar Pharmaceuticals Announces Plans to Launch a New eCommerce Sales Platform 24

Appendix 25

Methodology 25

About GlobalData 25

Contact Us 25

Disclaimer 25


List Of Figure

List of Figures

BioStar Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

BioStar Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

BioStar Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

BioStar Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

BioStar Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

BioStar Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

BioStar Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

BioStar Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8


List Of Table

List of Tables

BioStar Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Key Facts 2

BioStar Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

BioStar Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

BioStar Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

BioStar Pharmaceuticals Inc, Deals By Therapy Area, 2012 to YTD 2018 8

BioStar Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9

Biostar Pharma Enters into R&D Agreement with Northwest University 10

Biostar Pharma Enters Into Co-Development Agreement With Shaanxi University of Chinese Medicine For Liver Cancer Drug 11

Biostar Pharma Enters Into Co-Development Agreement With Fourth Military Medical University 12

Biostar Pharma Raises USD2 Million in Private Placement of Shares 13

Biostar Pharma Announces Private Placement Of Shares And Warrants For USD 4 Million 14

Biostar Pharma to Acquire Xianyang Yongsheng Health Products 15

BioStar Pharmaceuticals Inc, Key Competitors 16

BioStar Pharmaceuticals Inc, Key Employees 17

BioStar Pharmaceuticals Inc, Subsidiaries 18

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS